The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | Occurrence & importance of endemic variants causing ATTRv in different regions of the world
Fernando de Frutos, MD, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain, comments on the occurrence of endemic variants causing hereditary transthyretin (ATTRv) amyloidosis in Spain, Portugal, and Latin America. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
